Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR

Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yunjie Huang, Kavisha Arora, Kyu Shik Mun, Fanmuyi Yang, ChangSuk Moon, Sunitha Yarlagadda, Anil Jegga, Timothy Weaver, Anjaparavanda P. Naren
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9ead2c7e3d246a98726846c361c73db
record_format dspace
spelling oai:doaj.org-article:a9ead2c7e3d246a98726846c361c73db2021-12-02T15:08:21ZTargeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR10.1038/s41598-019-46161-42045-2322https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db2019-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-46161-4https://doaj.org/toc/2045-2322Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal co-chaperone, DNAJB9, which can directly interact with CFTR. For both WT- and ΔF508 (deletion of phenylalanine at position 508, the most common CF-causing mutant)-CFTR, knockdown of DNAJB9 by siRNA increased their expression levels on the cell surface and, consequently, upregulated their function. Furthermore, genetic ablation of DNAJB9 in WT mice increased CFTR expression and enhanced CFTR-dependent fluid secretion in enteroids. Importantly, DNAJB9 deficiency upregulated enteroids’ fluid secretion in CF mice (homozygous for ΔF508), and silencing one allele of DNAJB9 is sufficient to rescue ΔF508-CFTR in vitro and in vivo, suggesting that DNAJB9 may be a rate-limiting factor in CFTR ERAD pathway. Our studies identified the first ER luminal co-chaperone involved in CFTR ERAD, and DNAJB9 could be a novel therapeutic target for CF.Yunjie HuangKavisha AroraKyu Shik MunFanmuyi YangChangSuk MoonSunitha YarlagaddaAnil JeggaTimothy WeaverAnjaparavanda P. NarenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yunjie Huang
Kavisha Arora
Kyu Shik Mun
Fanmuyi Yang
ChangSuk Moon
Sunitha Yarlagadda
Anil Jegga
Timothy Weaver
Anjaparavanda P. Naren
Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
description Abstract The molecular mechanism of Endoplasmic Reticulum-associated degradation (ERAD) of Cystic fibrosis transmembrane-conductance regulator (CFTR) is largely unknown. Particularly, it is unknown what ER luminal factor(s) are involved in ERAD. Herein, we used ProtoArray to identify an ER luminal co-chaperone, DNAJB9, which can directly interact with CFTR. For both WT- and ΔF508 (deletion of phenylalanine at position 508, the most common CF-causing mutant)-CFTR, knockdown of DNAJB9 by siRNA increased their expression levels on the cell surface and, consequently, upregulated their function. Furthermore, genetic ablation of DNAJB9 in WT mice increased CFTR expression and enhanced CFTR-dependent fluid secretion in enteroids. Importantly, DNAJB9 deficiency upregulated enteroids’ fluid secretion in CF mice (homozygous for ΔF508), and silencing one allele of DNAJB9 is sufficient to rescue ΔF508-CFTR in vitro and in vivo, suggesting that DNAJB9 may be a rate-limiting factor in CFTR ERAD pathway. Our studies identified the first ER luminal co-chaperone involved in CFTR ERAD, and DNAJB9 could be a novel therapeutic target for CF.
format article
author Yunjie Huang
Kavisha Arora
Kyu Shik Mun
Fanmuyi Yang
ChangSuk Moon
Sunitha Yarlagadda
Anil Jegga
Timothy Weaver
Anjaparavanda P. Naren
author_facet Yunjie Huang
Kavisha Arora
Kyu Shik Mun
Fanmuyi Yang
ChangSuk Moon
Sunitha Yarlagadda
Anil Jegga
Timothy Weaver
Anjaparavanda P. Naren
author_sort Yunjie Huang
title Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
title_short Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
title_full Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
title_fullStr Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
title_full_unstemmed Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR
title_sort targeting dnajb9, a novel er luminal co-chaperone, to rescue δf508-cftr
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/a9ead2c7e3d246a98726846c361c73db
work_keys_str_mv AT yunjiehuang targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT kavishaarora targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT kyushikmun targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT fanmuyiyang targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT changsukmoon targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT sunithayarlagadda targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT aniljegga targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT timothyweaver targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
AT anjaparavandapnaren targetingdnajb9anovelerluminalcochaperonetorescuedf508cftr
_version_ 1718388204823904256